Kerry S. Campbell

Kerry Campbell practices at Dedicated To Women OB-GYN, P.A. in Middletown, Delaware.

Kerry Campbell's NPI, 1053852251, was assigned on March 20, 2017. Kerry Campbell graduated from University of Maryland School of Medicine in 2017. Kerry Campbell holds Delaware license C1-0024369.

Kerry Campbell's primary practice is Dedicated To Women OB-GYN, P.A., at 118 Sandhill Dr, Middletown, DE 19709 in New Castle County. The practice phone is (302) 674-0223.

Kerry Campbell's primary practice is Dedicated To Women OB-GYN, P.A. in Middletown, Delaware. Kerry Campbell is also affiliated with Christiana Hospital. The medical group on file is Dedicated to Women OB/GYN. Dmand AI also links Kerry Campbell to 2 more hospitals, 1 group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Kerry Campbell practices, 4 sites in all. Vendor and product names are available with a free account.

Obstetrics and gynecology is Kerry Campbell's primary specialty in the NPI Registry, under taxonomy code 207V00000X. Kerry Campbell is licensed in Delaware.

CMS data shows 203 Medicare services from Kerry Campbell across 6 procedure codes in 2024, for 111 Medicare patients. Medicare paid $10,194 for them. Every service was in an office.

CMS counts 111 Medicare patients who saw Kerry Campbell in 2024. The largest group is 65 to 74, with 60 patients. 75% of them have high cholesterol, and 67% have high blood pressure. 12% are also on Medicaid. Their average risk score is 0.85, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Kerry Campbell's median patient age at 38, with 100% women.

In 2024, Kerry Campbell wrote 233 Medicare Part D claims for 83 patients. 81% of them were for generic drugs. CMS names the drug for 84 of them, across 4 drugs with 11 or more claims each, at $5,466 in total drug cost. In 2023, CMS named 35 claims across 3 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 88 out of 100 for Kerry Campbell for performance year 2024, reported as part of a group. Kerry Campbell accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Kerry Campbell as offering telehealth.

Removal of the uterus: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 63 papers to Kerry Campbell, published from 2011 to 2025. 2017 was the busiest year, with 6. The most frequent topics are Killer Cells, Natural, Cell Line, Tumor and Natural Cytotoxicity Triggering Receptor 2. Kerry Campbell has published most often in Oncotarget. Kerry Campbell's most frequent co-authors are Michael D. Robbins, MD, Elizabeth R. Plimack, MD and Stefan Klaus Barta, MD.

CMS Open Payments shows 106 general payments to Kerry Campbell from 24 drug and device companies from 2017 to 2025. Food and beverage make up the largest share, 95% of the total. Evofem Biosciences, Inc. paid the most, $283.

Kerry Campbell graduated from University of Maryland School of Medicine in 2017.